Glenn Huybrecht

The case investigates the impact of the increasing trend of pharmaceutical firms to outsource core research activities to biotech firms and other contract research organizations. The fluid nature of supply chain design in evolving industries is highlighted, and robust supply chain policies to respond to this evolution are proposed.

Published 27 Feb 2012

Reference 5812

Topic Operations

Industry Pharmaceuticals

Region Global

View case